Mechanism-based inactivation of cytochrome P450 2D6 by Notopterol

被引:8
作者
Fu, Yao [1 ]
Tian, Xiaoxiao [1 ]
Han, Lingling [1 ]
Li, Yilin [1 ]
Peng, Ying [1 ]
Zheng, Jiang [1 ,2 ,3 ]
机构
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Shenyang 110016, Liaoning, Peoples R China
[2] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Key Lab Pharmaceut Guizhou Prov, Guiyang 550025, Guizhou, Peoples R China
[3] Guizhou Med Univ, Key Lab Environm Pollut Monitoring & Dis Control, Minist Educ, Guiyang 550025, Peoples R China
基金
中国国家自然科学基金;
关键词
Notopterol; Mechanism-based inactivation; CYP450; DRUG INTERACTION; IN-VITRO; CYP2D6; INHIBITION;
D O I
10.1016/j.cbi.2020.109053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Notopterol (NOT) is a major bioactive ingredient extracted from the rhizomes of either Notopterygium incisum Ting ex H. T. Chang or N. forbesii Boiss (Qianghuo in Chinese), a botanical drug that was adopted as a traditional Chinese medicine. NOT is suggested to show analgesic and anti-inflammatory effects in clinical practice. The inhibitory effects of NOT on human cytochrome P450 enzymes were investigated in the present study. Our results indicate that NOT inhibited the activity of CYP2D6 in a time-, concentration- and NADPH-dependent manner. The values of k(1) and k(in)(act) were 10.8 mu M and 0.62 min(-1), respectively. The calculated k(obs) at 10 mu M was 0.29 min(-1), above the 0.02 min(-1) risk level. After incubation with NOT at 10 mu M for 9 min, approximately 92% of CYP2D6 activity was inhibited. Such loss of enzyme activity was not restored through dialysis, which indicates that the observed enzyme inhibition was irreversible. Partition ratio of the inactivation was approximately 29. Quinidine, a competitive CYP2D6 inhibitor, demonstrated protection on enzymes against the NOT-induced inactivation, but such protection was not found in incubation systems fortified with glutathione or catalase/superoxide dismutase. Additionally, CYP3A4 was observed to function as an enzyme mainly involved in the biotransformation of NOT. Taken together, these findings indicate that NOT served as a mechanism-based inactivator of CYP2D6, meanwhile, those observed effects may induce the latent drug-drug interactions. The metabolic activation of NOT may be the key to trigger the inactivation of the enzyme.
引用
收藏
页数:9
相关论文
共 50 条
[21]   Mechanism-Based Inactivation of Cytochrome P450 2C9 by Tienilic Acid and (±)-Suprofen: A Comparison of Kinetics and Probe Substrate Selection [J].
Hutzler, J. Matthew ;
Balogh, Larissa M. ;
Zientek, Michael ;
Kumar, Vikas ;
Tracy, Timothy S. .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (01) :59-65
[22]   Mechanism-based inactivation of cytochrome P450 3A4 by methylenedioxyphenyl lignans from Aconthoponox chiisonensis [J].
Yoo, Hye Hyun ;
Lee, Sang-Hyun ;
Jin, Changbae ;
Kim, Dong-Hyun .
PLANTA MEDICA, 2008, 74 (08) :822-827
[23]   Mechanism-based inactivation of human cytochrome P450 1A2 and 3A4 isoenzymes by anti-tumor triazoloacridinone C-1305 [J].
Potega, Agnieszka ;
Fedejko-Kap, Barbara ;
Mazerska, Zofia .
XENOBIOTICA, 2016, 46 (12) :1056-1065
[24]   Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism [J].
Unwalla, Rayomand J. ;
Cross, Jason B. ;
Salaniwal, Sumeet ;
Shilling, Adam D. ;
Leung, Louis ;
Kao, John ;
Humblet, Christine .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2010, 24 (03) :237-256
[25]   Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4 [J].
Guo, Xiucai ;
Li, Wei ;
Li, Qingmei ;
Chen, Yan ;
Zhao, Guode ;
Peng, Ying ;
Zheng, Jiang .
CHEMICAL RESEARCH IN TOXICOLOGY, 2019, 32 (09) :1791-1800
[26]   Methysticin Acts as a Mechanism-Based Inactivator of Cytochrome P450 2C9 [J].
Zhang, Qiuying ;
Liu, Hui ;
Wu, Dongmei ;
Yu, Hongyan ;
Wang, Kun ;
Jiao, Weijie ;
Zhao, Xu .
CHEMICAL RESEARCH IN TOXICOLOGY, 2022, 35 (06) :1117-1124
[27]   Mechanism-Based Inactivation of Human Cytochrome P450 3A4 by Two Piperazine-Containing Compounds [J].
Bolles, Amanda K. ;
Fujiwara, Rina ;
Briggs, Erran D. ;
Nomeir, Amin A. ;
Furge, Laura Lowe .
DRUG METABOLISM AND DISPOSITION, 2014, 42 (12) :2087-2096
[28]   Mechanism-based inactivation of cytochrome P450 2B4 by aldehydes: Relationship to aldehyde deformylation via a peroxyhemiacetal intermediate [J].
Raner, GM ;
Chiang, EW ;
Vaz, ADN ;
Coon, MJ .
BIOCHEMISTRY, 1997, 36 (16) :4895-4902
[29]   Lack of mechanism-based inactivation of rat hepatic microsomal cytochromes P450 by doxorubicin [J].
Di Re, J ;
Lee, C ;
Riddick, DS .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1999, 77 (08) :589-597
[30]   Efficacy of Tramadol for Pain Management in Patients Receiving Strong Cytochrome P450 2D6 Inhibitors [J].
Frost, Derek A. ;
Soric, Mate M. ;
Kaiser, Ricky ;
Neugebauer, Rachel E. .
PHARMACOTHERAPY, 2019, 39 (06) :724-729